Cochrane Abstracts
Tocilizumab for giant cell arteritis Edited (no change to conclusions)
Tocilizumab for giant cell arteritis Edited (no change to conclusions) is a topic covered in the Cochrane Abstracts.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this entry is available only to subscribers.
Citation
"Tocilizumab for Giant Cell Arteritis Edited (no Change to Conclusions)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439304/all/Tocilizumab_for_giant_cell_arteritis_New. Accessed 28 June 2022.
Tocilizumab for giant cell arteritis Edited (no change to conclusions). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439304/all/Tocilizumab_for_giant_cell_arteritis_New. Accessed June 28, 2022.
Tocilizumab for giant cell arteritis Edited (no change to conclusions). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439304/all/Tocilizumab_for_giant_cell_arteritis_New
Tocilizumab for Giant Cell Arteritis Edited (no Change to Conclusions) [Internet]. In: Cochrane Abstracts. [cited 2022 June 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439304/all/Tocilizumab_for_giant_cell_arteritis_New.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tocilizumab for giant cell arteritis Edited (no change to conclusions)
ID - 439304
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439304/all/Tocilizumab_for_giant_cell_arteritis_New
DB - Evidence Central
DP - Unbound Medicine
ER -
